Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine

Carbamazepine (CBZ) is a first generation anti-seizure drug, considered as first choice therapy in focal epilepsy but associated with cognitive side effects. Lacosamide (LCM) is a third-generation anti-seizure drug approved for treating focal epilepsy. This case series documented the comparable effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liguori, Claudio, Izzi, Francesca, Manfredi, Natalia, Mercuri, Nicola Biagio, Placidi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030027/
https://www.ncbi.nlm.nih.gov/pubmed/29977793
http://dx.doi.org/10.1016/j.ebcr.2018.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030027/
https://www.ncbi.nlm.nih.gov/pubmed/29977793
http://dx.doi.org/10.1016/j.ebcr.2018.02.004

Ejemplares similares